LifeMD Inc [LFMD] stock is trading at $6.53, up 4.65%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LFMD shares have gain 17.24% over the last week, with a monthly amount glided 17.87%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeMD Inc [NASDAQ: LFMD] stock has seen the most recent analyst activity on December 10, 2024, when Lake Street initiated its Buy rating and assigned the stock a price target of $12. Previously, Mizuho started tracking the stock with Neutral rating on December 04, 2024, and set its price target to $7. KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and suggested a price target of $12 on June 05, 2024. Craig Hallum initiated its recommendation with a Buy and recommended $10 as its price target on November 30, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on July 21, 2023, and assigned it a price target of $7. In a note dated July 03, 2023, H.C. Wainwright initiated an Buy rating and provided a target price of $9 on this stock.
LifeMD Inc [LFMD] stock has fluctuated between $3.99 and $12.88 over the past year. Currently, Wall Street analysts expect the stock to reach $10.33 within the next 12 months. LifeMD Inc [NASDAQ: LFMD] shares were valued at $6.53 at the most recent close of the market. An investor can expect a potential return of 58.19% based on the average LFMD price forecast.
Analyzing the LFMD fundamentals
LifeMD Inc [NASDAQ:LFMD] reported sales of 193.06M for the trailing twelve months, which represents a growth of 38.27%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.12%, and Net Profit Margin reading is -0.13%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is 10.05 and Total Capital is -0.87. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.22 points at the first support level, and at 5.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.84, and for the 2nd resistance point, it is at 7.15.
Ratios To Look Out For
For context, LifeMD Inc’s Current Ratio is 0.83. Also, the Quick Ratio is 0.78, while the Cash Ratio stands at 0.64. Considering the valuation of this stock, the price to sales ratio is 1.46.
Transactions by insiders
Recent insider trading involved Schreiber Justin, Chief Executive Officer, that happened on Jan 02 ’25 when 25000.0 shares were sold. Chief Executive Officer, Schreiber Justin completed a deal on Dec 02 ’24 to sell 25000.0 shares. Meanwhile, CEO Justin Schreiber bought 100000.0 shares on Dec 02 ’24.
